Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
1,137
currently held
Exits tracked
410
hand-checked
Sectors covered
1
across the portfolio
Countries covered
38
from every market
1,419 companies matching · Page 28 of 29
Riva Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
RoukenBio
NorthEdge Fund III
Sector
Biotech
InvestorNorthEdge Capital
Entry
2023
Hold
3yr
Rubedo Life Sciences
Oscar & Paul Venture Capital Fund I
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Ruby Bio
Nucleus Capital II
Sector
Biotech
InvestorNucleus Capital
Entry
2025
Hold
1yr
Sable Bio
MMC Ventures EIS Fund
Sector
Biotech
InvestorMMC Ventures
Entry
2025
Hold
1yr
SACRA Therapeutics
Eir Ventures I
Sector
Biotech
InvestorEir Ventures
Entry
2021
Hold
5yr
Sangon Biotech
Novo Holdings Growth Investments
China
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Sarkana Pharma, Inc.
TVM Life Science Innovation
Canada
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
ScandiBio
Navigare Ventures
Sector
Biotech
InvestorNavigare Ventures
Entry
2018
Hold
8yr
Sengenics
Summa Equity Fund II
Singapore
Sector
Biotech
InvestorSumma Equity
Entry
2020
Hold
6yr
Sensible Biotechnologies
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Sidera Bio
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
SideROS
Erganeo
Sector
Biotech
InvestorErganeo
Entry
2019
Hold
7yr
Signatope
HTGF II
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2016
Hold
10yr
Silk Biomaterials
Principia III - Health
Sector
Biotech
InvestorPrincipia SGR
Entry
2016
Hold
10yr
Sim&Cure
Elaia Delta Fund
Sector
Biotech
InvestorElaia Partners
Entry
2019
Hold
7yr
Single Technologies AB
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr
Sorriso Pharmaceuticals
Lundbeckfonden BioCapital
Sector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2021
Hold
5yr
Sortina Pharma
Eir Ventures I
Sector
Biotech
InvestorEir Ventures
Entry
2020
Hold
6yr
Souffle Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2025
Hold
1yr
Stayble Therapeutics
Chalmers Ventures
Sector
Biotech
InvestorChalmers Ventures
Entry
2016
Hold
10yr
StemTek Therapeutics
Fondo BI
Sector
Biotech
InvestorSeed Capital de Bizkaia
Entry
2016
Hold
10yr
Strand Therapeutics
Kinnevik
Sector
Biotech
InvestorKinnevik
Entry
2025
Hold
1yr
Stroma Care
Capital Santé 2
Sector
Biotech
InvestorTurenne Groupe
Entry
2022
Hold
4yr
Stromacare
Capital Santé 2
Sector
Biotech
InvestorTurenne Groupe
Entry
2022
Hold
4yr
Sudo Biosciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
SVF Vaccines
Karolinska Development
Sector
Biotech
InvestorKarolinska Development
Entry
2020
Hold
6yr
SwitchKine
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
Synboli
AVA 1 (Aquiti Venture Amorcage)
Sector
Biotech
InvestorAquiti Gestion
Entry
2025
Hold
1yr
Syngoi Technologies
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr
Synklino
EIFO (direct equity)
Sector
Biotech
InvestorEifo
Entry
2020
Hold
6yr
SynOx Therapeutics Ltd
HealthCap VII
Sector
Biotech
InvestorHealthCap
Entry
2020
Hold
6yr
Synthetica Pioneering
Boehringer Ingelheim Venture Fund
China
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
T-Curx
Seedfonds Bayern
Sector
Biotech
InvestorBayern Kapital
Entry
2025
Hold
1yr
T-One Therapeutics
Utopia SIS
Sector
Biotech
InvestorUtopia SIS
Entry
2022
Hold
4yr
T7 Therapeutics
TVM Life Science Innovation
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
TargED Biopharmaceuticals
Sunstone Life Science Ventures V
Sector
Biotech
InvestorSunstone Life Science Ventures
Entry
2022
Hold
4yr
Targedys
Health for Life Capital
Sector
Biotech
InvestorSeventure Partners
Entry
2019
Hold
7yr
Tarveda Therapeutics
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
TECregen
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2023
Hold
3yr
Ternary Therapeutics
Daphni Blue
Sector
Biotech
InvestorDaphni
Entry
2025
Hold
1yr
Terremoto Biosciences
Novo Holdings Venture Investments
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Thelior Bio
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2025
Hold
1yr
Third Harmonic Bio
General Atlantic
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
TIBEAY Biosciences
MIG Fonds 18
Sector
Biotech
InvestorMIG Capital
Entry
2026
Hold
0yr
Timberlyne Therapeutics
Abingworth Bioventures 8
Sector
Biotech
InvestorAbingworth
Entry
2025
Hold
1yr
TolemyBio
JME Ventures IV
Sector
Biotech
InvestorJME Ventures
Entry
2026
Hold
0yr
TRIM TX
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2025
Hold
1yr
Twogee Biotech
Seedfonds Bayern
Sector
Biotech
InvestorBayern Kapital
Entry
2026
Hold
0yr
Umecrine Cognition
Almi Invest (Regional funds)
Sector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
10yr